|
Market Closed -
NSE India S.E.
07:05:07 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 2,226.70 INR | -1.06% |
|
+1.57% | +9.41% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
| Market Cap | 628B 6.62B 5.89B 5.45B 4.97B 9.36B 9.53B 65.5B 25.71B 328B 24.83B 24.3B 1,046B | P/E 2027 * |
27.2x | P/E 2028 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 593B 6.24B 5.55B 5.14B 4.68B 8.83B 8.99B 61.77B 24.25B 309B 23.42B 22.92B 986B | EV / Sales 2027 * |
3.5x | EV / Sales 2028 * | 3.1x |
| Free-Float |
51.04% | Yield 2027 * |
0.17% | Yield 2028 * | 0.18% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -1.06% | ||
| 1 week | +1.57% | ||
| Current month | -4.63% | ||
| 1 month | -6.11% | ||
| 3 months | -3.08% | ||
| 6 months | -1.40% | ||
| Current year | +9.41% |
| 1 week | 2,223.7 |  | 2,293.9 |
| 1 month | 2,181.2 | | 2,482.6 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,792.6 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 1999-12-31 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 2025-05-26 |
Indrajit Bose
PSD | President | - | 2023-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 2011-05-11 | |
| Director/Board Member | 86 | 2009-08-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.06% | +1.57% | +17.55% | +178.91% | 6.71B | |
| +0.43% | +7.48% | +52.08% | +106.34% | 1,116B | |
| +0.90% | -0.36% | +33.68% | +62.93% | 610B | |
| +0.71% | +4.77% | +26.17% | +92.90% | 501B | |
| +0.52% | +2.51% | +73.52% | +40.32% | 358B | |
| -0.13% | +7.51% | +33.47% | +48.68% | 366B | |
| -0.95% | +5.93% | +19.86% | +42.48% | 288B | |
| -1.98% | +4.66% | -1.57% | +13.41% | 261B | |
| -0.35% | +6.15% | +45.46% | +52.23% | 235B | |
| -0.75% | +6.18% | +32.03% | +101.15% | 195B | |
| Average | -0.36% | +5.00% | +33.23% | +73.94% | 393.65B | |
| Weighted average by Cap. | -0.10% | +4.93% | +38.79% | +72.34% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 169B 1.79B 1.59B 1.47B 1.34B 2.52B 2.57B 17.67B 6.94B 88.38B 6.7B 6.56B 282B | 187B 1.97B 1.75B 1.62B 1.48B 2.79B 2.84B 19.52B 7.66B 97.67B 7.4B 7.24B 312B |
| Net income | 23.69B 250M 222M 206M 187M 353M 359M 2.47B 970M 12.35B 936M 916M 39.43B | 28.32B 298M 265M 246M 224M 422M 430M 2.95B 1.16B 14.77B 1.12B 1.1B 47.13B |
| Net Debt | -35.75B -377M -335M -310M -283M -532M -542M -3.73B -1.46B -18.64B -1.41B -1.38B -59.49B | -47.16B -497M -442M -409M -373M -702M -715M -4.92B -1.93B -24.59B -1.86B -1.82B -78.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | ₹2,226.70 | -1.06% | 695,427 |
| 26-10-15 | ₹2,250.50 | +0.20% | 488,525 |
| 26-10-14 | ₹2,246.00 | -0.85% | 257,936 |
| 26-10-13 | ₹2,265.30 | -0.78% | 259,977 |
| 26-10-12 | ₹2,283.00 | -0.44% | 695,528 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
